Log in

NASDAQ:DADALegend Biotech Stock Price, Forecast & News

$26.38
+3.23 (+13.95 %)
(As of 07/3/2020 04:00 PM ET)
Add
Today's Range
$23.70
Now: $26.38
$26.40
50-Day Range N/A
52-Week Range
$14.60
Now: $26.38
$26.40
Volume2.03 million shs
Average Volume2.40 million shs
Market Capitalization$5.86 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
New Dada owns and operates an online crowdsourcing logistics portal and provides local instant delivery service. The company was formerly known as Dada Nexus Limited and changed its name to New Dada in April 2016. New Dada was founded in 2014 and is based in Shanghai, China.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 1.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.20 out of 5 stars


Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolNASDAQ:DADA
CUSIPN/A
CIKN/A
Phone86-21-3165-7167

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees2,149
Market Cap$5.86 billion
Next Earnings DateN/A
OptionableNot Optionable

Receive DADA News and Ratings via Email

Sign-up to receive the latest news and ratings for DADA and its competitors with MarketBeat's FREE daily newsletter.

Legend Biotech (NASDAQ:DADA) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of Legend Biotech?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Legend Biotech in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Legend Biotech.

What price target have analysts set for DADA?

1 equities research analysts have issued 12 month target prices for Legend Biotech's stock. Their forecasts range from $22.00 to $22.00. On average, they anticipate Legend Biotech's share price to reach $22.00 in the next year. This suggests that the stock has a possible downside of 16.6%. View analysts' price targets for Legend Biotech.

Has Legend Biotech been receiving favorable news coverage?

Press coverage about DADA stock has been trending negative recently, InfoTrie reports. InfoTrie identifies negative and positive media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Legend Biotech earned a coverage optimism score of -2.8 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 7.0 out of 10, indicating that recent media coverage is likely to have an impact on the company's share price in the near future. View the latest news about Legend Biotech.

Who are Legend Biotech's key executives?

Legend Biotech's management team includes the following people:
  • Mr. Philip Jiaqi Kuai, CEO, Founder & Chairman (Age 37)
  • Mr. Jun Yang, CTO & Co-Founder (Age 42)
  • Mr. Zhaoming Chen Beck, Chief Financial Officer (Age 37)

When did Legend Biotech IPO?

(DADA) raised $264 million in an initial public offering on Friday, June 5th 2020. The company issued 16,500,000 shares at a price of $15.00-$17.00 per share. Goldman Sachs (Asia), BofA Securities and Jefferies served as the underwriters for the IPO.

What is Legend Biotech's stock symbol?

Legend Biotech trades on the NASDAQ under the ticker symbol "DADA."

When does Legend Biotech's quiet period expire?

Legend Biotech's quiet period expires on Wednesday, July 15th. Legend Biotech had issued 20,000,000 shares in its public offering on June 5th. The total size of the offering was $320,000,000 based on an initial share price of $16.00. During Legend Biotech's quiet period, insiders and underwriters involved in the IPO are prevented from issuing any earnings forecasts or research reports for the company because of regulations issued by the Securities and Exchange Commission. Following the end of the company's quiet period, it's expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.

How do I buy shares of Legend Biotech?

Shares of DADA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Legend Biotech's stock price today?

One share of DADA stock can currently be purchased for approximately $26.38.

How big of a company is Legend Biotech?

Legend Biotech has a market capitalization of $5.86 billion. Legend Biotech employs 2,149 workers across the globe.

What is Legend Biotech's official website?

The official website for Legend Biotech is about.imdada.cn.

How can I contact Legend Biotech?

Legend Biotech's mailing address is 22F ORIENTAL FISHERMAN`S WHARF NO. 1088 YANGSHUPU ROAD YANGPU DISTRCT, SHANGHAI F4, 200082. The company can be reached via phone at 86-21-3165-7167 or via email at [email protected]

This page was last updated on 7/4/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.